Literature DB >> 2503177

Tissue response of gastric mucosa after ingestion of fluoride.

C J Spak1, S Sjöstedt, L Eleborg, B Veress, L Perbeck, J Ekstrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2503177      PMCID： PMC1836770          DOI： 10.1136/bmj.298.6689.1686

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  The effects of fluoride on the gastric mucosa of the rat.

Authors:  D H Pashley; N B Allison; R P Easmann; R V McKinney; J A Horner; G M Whitford
Journal:  J Oral Pathol       Date:  1984-10

2.  Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents.

Authors:  F L Lanza
Journal:  Am J Med       Date:  1984-07-13       Impact factor: 4.965

3.  Clinical application of topical fluoride products--risks, benefits, and recommendations.

Authors:  E J Lecompte
Journal:  J Dent Res       Date:  1987-05       Impact factor: 6.116

4.  Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence.

Authors:  B L Riggs; S F Hodgson; D L Hoffman; P J Kelly; K A Johnson; D Taves
Journal:  JAMA       Date:  1980-02-01       Impact factor: 56.272

5.  Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis.

Authors:  N Mamelle; P J Meunier; R Dusan; M Guillaume; J L Martin; A Gaucher; A Prost; G Zeigler; P Netter
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321
  5 in total
  7 in total

1.  Fluoride treatment in osteoporosis.

Authors:  P Pitt; H Berry
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

2.  Treatment of postmenopausal vertebral osteopenia with monofluorophospate: a long-term calcium-controlled study.

Authors:  M Gambacciani; A Spinetti; F Taponeco; L Piaggesi; B Cappagli; M Ciaponi; L C Rovati; A R Genazzani
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

3.  Gastroduodenal manifestations in patients with skeletal fluorosis.

Authors:  S Dasarathy; T K Das; I P Gupta; A K Susheela; R K Tandon
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

4.  Tissue response of gastric mucosa after ingestion of fluoride.

Authors: 
Journal:  BMJ       Date:  1989-07-29

5.  Serum fluoride and serum osteocalcin levels in response to a novel sustained-release monofluorophosphate preparation: comparison with plain monofluorophosphate.

Authors:  A Battmann; H Resch; C R Libanati; D Ludy; M Fischer; S Farley; D J Baylink
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

6.  Pharmacokinetic profile of a new fluoride preparation: sustained-release monofluorophosphate.

Authors:  H Resch; C Libanati; J Talbot; M Tabuenca; S Farley; P Bettica; W Tritthart; D Baylink
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

7.  Effects of fluoride on structure and function of canine gastric mucosa.

Authors:  G M Whitford; D H Pashley; R H Garman
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.